While investigating the high expression level of SETD6 in prostate cancer, Kublanovsky and colleagues discovered that E2F1 occupies the SETD6 promoter and upregulates SETD6 mRNA expression27. This evidence concerns the gene E2F1 and prostate carcinoma.